Sentio will produce propofol and bupivacaine, both of which have been in short supply. Financial terms of the contract have not been released. Propofol is used for general anesthesia and bupivacaine as a local anesthetic.
Sentio was founded in 2009 and develops products used in human and animal health, including two medications approved by the FDA.
APIIC is currently working on developing six drugs. The nonprofit recently received $14 million from HHS to produce three critical active pharmaceutical ingredients used to treat asthma, diabetes and anxiety disorders.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.